PURRELLO, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 14.611
AS - Asia 6.668
EU - Europa 6.207
SA - Sud America 1.468
AF - Africa 945
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 9
Totale 29.920
Nazione #
US - Stati Uniti d'America 14.126
SG - Singapore 3.624
IT - Italia 2.062
CN - Cina 1.869
IE - Irlanda 1.302
BR - Brasile 1.282
UA - Ucraina 1.024
RU - Federazione Russa 666
CI - Costa d'Avorio 589
CA - Canada 410
VN - Vietnam 341
IN - India 271
DE - Germania 243
SE - Svezia 234
SN - Senegal 202
GB - Regno Unito 165
KR - Corea 121
NL - Olanda 78
FI - Finlandia 73
AR - Argentina 69
FR - Francia 62
PL - Polonia 61
BD - Bangladesh 57
TR - Turchia 57
MX - Messico 49
ZA - Sudafrica 47
JP - Giappone 46
UZ - Uzbekistan 45
AT - Austria 42
CH - Svizzera 40
NG - Nigeria 38
HK - Hong Kong 36
EC - Ecuador 31
ES - Italia 30
IQ - Iraq 30
IR - Iran 30
CO - Colombia 24
GR - Grecia 22
MA - Marocco 21
CZ - Repubblica Ceca 20
ID - Indonesia 19
LB - Libano 19
PK - Pakistan 19
BE - Belgio 18
VE - Venezuela 17
BJ - Benin 14
CL - Cile 13
BG - Bulgaria 12
KE - Kenya 12
EU - Europa 11
LT - Lituania 11
PY - Paraguay 11
SA - Arabia Saudita 10
AL - Albania 9
AZ - Azerbaigian 9
PE - Perù 8
UY - Uruguay 8
RO - Romania 7
AU - Australia 6
IL - Israele 6
KW - Kuwait 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
HU - Ungheria 5
JO - Giordania 5
KG - Kirghizistan 5
NP - Nepal 5
OM - Oman 5
PA - Panama 5
PS - Palestinian Territory 5
TH - Thailandia 5
BO - Bolivia 4
DO - Repubblica Dominicana 4
IS - Islanda 4
MY - Malesia 4
RS - Serbia 4
BH - Bahrain 3
DZ - Algeria 3
HN - Honduras 3
JM - Giamaica 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
SV - El Salvador 3
AO - Angola 2
DK - Danimarca 2
EG - Egitto 2
ET - Etiopia 2
GE - Georgia 2
MD - Moldavia 2
MK - Macedonia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
BB - Barbados 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CD - Congo 1
CR - Costa Rica 1
Totale 29.902
Città #
Dallas 2.704
Singapore 2.007
Santa Clara 1.807
Chandler 1.407
Dublin 1.295
Jacksonville 1.073
Chicago 598
Abidjan 589
Boardman 546
Ashburn 491
Cambridge 356
Lawrence 355
Catania 353
Andover 348
Nanjing 343
Beijing 297
Hefei 293
Toronto 287
Civitanova Marche 253
Los Angeles 250
Wilmington 223
Dakar 202
Des Moines 188
Moscow 181
Kochi 176
San Mateo 168
Milan 162
Rome 160
Seoul 120
Ho Chi Minh City 104
New York 103
São Paulo 103
Nanchang 100
Shenyang 95
Padova 88
Hebei 86
Houston 86
Buffalo 81
The Dalles 78
Saint Petersburg 72
Dong Ket 67
Jiaxing 67
Ottawa 67
Columbus 61
Munich 60
Palermo 59
Hanoi 58
Bremen 55
Council Bluffs 51
Changsha 48
Warsaw 47
Grafing 45
Tianjin 44
Tokyo 44
Rio de Janeiro 42
Brooklyn 39
Montreal 38
San Francisco 37
Abuja 34
Belo Horizonte 33
Stockholm 32
Atlanta 31
Hong Kong 31
Naples 31
Seattle 31
Brasília 29
Helsinki 29
Johannesburg 29
Lappeenranta 27
Phoenix 27
Boston 25
Denver 25
Istanbul 24
Poplar 24
Amsterdam 23
London 23
Messina 23
Pune 23
Redondo Beach 23
Washington 22
Augusta 21
Chennai 21
Orem 21
Den Haag 20
Boydton 19
Kunming 19
Carrara 18
Norwalk 18
Campinas 17
Porto Alegre 17
Tashkent 17
Turku 17
Jinan 15
Leawood 15
Cotonou 14
Curitiba 14
Guayaquil 14
Manchester 14
Salvador 14
Ankara 13
Totale 20.094
Nome #
IL DIABETE MELLITO AUMENTA LE RESISTENZE ARTERIOSE RENALI NEI PAZIENTI CON CIRROSI EPATICA 704
Long-term preservation of kidney function with SGLT-2 inhibitors versus comparator drugs in people with type 2 diabetes and chronic kidney disease 371
Criteri IDF e ATP-III per la diagnosi di sindrome metabolica: relazione con la prevalenza di steatosi epatica 247
1 h Postload Glycemia Is Associated with Low Endogenous Secretory Receptor for Advanced Glycation End Product Levels and Early Markers of Cardiovascular Disease 212
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 180
Critical appraisal of the European Union Scientific Committee on Health, Environmental, and Emergency Risks (SCHEER) Preliminary Opinion on electronic cigarettes 159
The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia 151
Il Rasario. Semeiotica medica 150
An Uncharacterised lncRNA Coded by the ASAP1 Locus Is Downregulated in Serum of Type 2 Diabetes Mellitus Patients 141
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 139
Controlling Nutritional Status (CONUT) Score as a Potential Prognostic Indicator of In-Hospital Mortality, Sepsis and Length of Stay in an Internal Medicine Department 138
Chronic exposure to palmitate impairs insulin signaling in an intestinal L-cell line: A possible shift from GLP-1 to glucagon production 133
A ten-year (1989-1998) perspective study of the incidence of Type 1 diabetes in the district of Catania (Sicily) in a 0-14 year age group 132
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 130
COPPER ADDITION PREVENTS THE INHIBITORY EFFECTS OF INTERLEUKIN-1-BETA ON RAT PANCREATIC-ISLETS 129
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 129
A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets 128
Antibiotic use and associated factors in a large sample of hospitalised older people 127
Cellular and molecular effects of protons: Apoptosis induction and potential implications for cancer therapy 125
Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance 123
HbA1c identifies subjects with prediabetes and subclinical left ventricular diastolic dysfunction 123
Analysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation 123
Analysis of S100A12 plasma levels in hyperlipidemic subjects with or without familial hypercholesterolemia 122
Atorvastatin but not pravastatin impairs mitochondrial function in human pancreatic islets and rat β-cells. Direct effect of oxidative stress 121
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 121
Chronic Exposure to GLP-1 Increases GLP-1 Synthesis and Release in a Pancreatic Alpha Cell Line (α-TC1): Evidence of a Direct Effect of GLP-1 on Pancreatic Alpha Cells 120
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritization and Network Analysis of New Candidate Genes from the Apoptotic Machinery 120
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritization and Network Analysis of New Candidate Genes from the Apoptotic Machinery 119
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 118
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritisation and Network Analysis of New Candidate Genes from the Apoptotic Machinery 114
Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes 114
Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two-Lipid Center Real-World Experience 114
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritization and Network Analysis of New Candidate Genes from the Apoptotic Machinery 113
(2012). Specifically different microRNAs profiles provide new insights on the molecular mechanisms activated by cytotoxic proinflammatory cytokines in mammalian pancreatic alpha and beta cells 113
Altered expression of uncoupling protein 2 in GLP-1-producing cells after chronic high glucose exposure: implications for the pathogenesis of diabetes mellitus. 113
High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes 112
Trattamento dell’ipercolesterolemia nel soggetto con diabete mellito: Aggiornamento sugli approcci terapeutici 112
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 112
Alterazioni lipidiche ed epatiche in soggetti con prediabete identificato in base all'emoglobina glicosilata 111
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 111
Cardiovascular Risk Profile in Subjects With Prediabetes and New-Onset Type 2 Diabetes Identified by HbA1c According to American Diabetes Association Criteria 110
Heart failure and chronic kidney disease in a registry of internal medicine wards 110
Action of insulin at the nuclear envelope 109
Early phase insulin secretion is increased in subjects with normal fasting glucose and metabolic syndrome: a premature feature of beta-cell dysfunction 109
Separate impact of metabolic syndrome and altered glucose tolerance on early markers of vascular injuries. 109
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 109
Altered expression of miRNAs and methylation of their promoters are correlated in neuroblastoma 107
A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus 107
Smoking and diabetes: Dangerous liaisons and confusing relationships 107
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritisation and Network Analysis of New Candidate Genes from the Apoptotic Machinery (AM) 106
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 106
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 106
Different effects of glucose and glyburide on insulin secretion in rat pancreatic islets pre-exposed to interleukin-1β. Possible involvement of K+ and Ca2+ channels 105
296-3p, miR-298-5p and their downstream networks are causally involved in the higher resistance of mammalian pancreatic α cells to cytokine-induced apoptosis as compared to β cells 105
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview 105
Impaired Glucagon Suppression And Reduced Insulin Sensitivity In Subjects With Prediabetes Undergoing Atorvastatin Therapy 105
Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk 104
An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects 104
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 104
Alterazioni della funzione diastolica in pazienti con diabete tipo 2 neodiagnosticato 103
Clinical and molecular biomarkers for diagnosis and staging of nafld 103
Circulating coding and long non-coding rnas as potential biomarkers of idiopathic pulmonary fibrosis 103
L’induzione di apoptosi da parte di protoni suggerisce innovative strategie terapeutiche anticancro 101
Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: a single lipid center real-world experience 101
Evaluation of high-density lipoprotein-bound long non-coding RNAs in subjects with familial hypercholesterolaemia 100
Effetti della glucotossicita' su una linea cellulare di L cellule intestinali (GLUTAg: Ruolo di UCP-2 100
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 100
Acute hyperbilirubinemia determines an early subclinical renal damage: Evaluation of tubular biomarkers in cholemic nephropathy 100
Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease 99
A molecular systems biomedicine approach to Diabetes: characterization, prioritization and network analysis of new candidate genes from the apoptotic machinery 99
Molecular Effects of Chronic Exposure to Palmitate in Intestinal Organoids: A New Model to Study Obesity and Diabetes 98
L’analogo dell’insulina Lispro riduce i picchi iperglicemici post-prandiali in soggetti con diabete tipo 2 98
Glucagon as a therapeutic approach to severe hypoglycemia: After 100 years, is it still the antidote of insulin? 97
Acidi grassi polinsaturi omega 3 (PUFA): studio pilota nella terapia della NAFDL 96
Analysis of gingival crevicular fluid biomarkers in patients with metabolic syndrome 96
Glucose regulates both glucose transport and the glucose transporter gene expression in a hamster-derived pancreatic Beta-cell line (HIT) 95
Correlazione fra patologia tiroidea e presenza di anticorpi antitireoglobulina ed antimicrosomi tiroidei 94
Low advanced glycation end product diet improves the lipid and inflammatory profiles of prediabetic subjects 94
Early effects of high-fat diet, extra-virgin olive oil and vitamin D in a sedentary rat model of non-alcoholic fatty liver disease. 94
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 94
Funzione mitocondriale in isole pancreatiche di pazienti con diabete tipo 2 93
Chronic exposure to glibenclamide impairs insulin secretion in isolated rat pancreatic islets 93
Role of ATP Production and Uncoupling Protein-2 in the Insulin Secretory Defect Induced by Chronic Exposure to High Glucose or Free Fatty Acids and Effects of Peroxisome Proliferator-Activated Receptor-gamma Inhibition 93
Direct effects of d-chiro-inositol on insulin signaling and glucagon secretion of pancreatic alpha cells 93
Chronic exposure to high leucine impairs glucose-induced insulin release by lowering the ATP to ADP ratio 92
VALUTAZIONE DELLA FUNZIONE BETA-CELLULARE NEGLI STADI PRECOCI DEL DIABETE MELLITO CON L'AUSILIO DI UN MODELLO MINIMO APPLICATO ALL'OGTT 92
New treatment options for lipid-lowering therapy in subjects with type 2 diabetes 92
Anticorpi anti-GH in soggetti in trattamento con ormone della crescita: incidenza e possibile ruolo degli aggregati dell'ormone nella loro genesi 92
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study 92
IN RAT PANCREATIC-ISLETS, IL-1-BETA INHIBITS INSULIN RELEASE BY A G-PROTEIN DEPENDENT MECHANISM 91
Inhibition of the high-affinity glucose transporter Glut-1 affects the sensitivity to glucose in a hamster-derived pancreatic beta cell line (HIT) 91
Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta cells 91
Porpora trombotica trombocitopenica e sindrome emolitico uremica: patologia ematologia, urgenza internistica 91
Acidi grassi polinsaturi omega 3 (PUFA): studio pilota nella terapia della NAFLD 91
A molecular Systems Medicine approach to Diabetes Mellitus pinpoints the molecular bases of the higher resistance to cytokine-induced apoptosis of mammalian pancreas α cells respect to β cells 91
Impact of Western and Mediterranean Diets and Vitamin D on Muscle Fibers of Sedentary Rats 91
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 91
Direct and indirect effects of sars-cov-2 pandemic in subjects with familial hypercholesterolemia: A single lipid-center real-world evaluation 91
Mitochondrial RNAs as Potential Biomarkers of Functional Impairment in Diabetic Kidney Disease 89
Interleukin-1ß inhibition of insulin release in rat pancreatic islets. Possible involvment of G-proteins in the signal transduction pathway 89
Totale 11.995
Categoria #
all - tutte 108.067
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.067


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.044 0 0 0 0 0 58 228 9 193 119 290 147
2021/20222.664 290 363 17 67 428 58 378 103 219 11 103 627
2022/20234.349 387 200 65 418 408 745 23 804 1.024 30 151 94
2023/20242.053 110 308 103 118 86 441 39 169 23 63 342 251
2024/20258.521 736 1.192 466 500 1.611 854 294 274 520 761 760 553
2025/20268.282 926 693 3.032 1.085 2.432 114 0 0 0 0 0 0
Totale 30.538